Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isoprinosine: an overview

L N Simon, A J Glasky

    Cancer Treatment Reports
    |November 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Isoprinosine exhibits low toxicity and effectively inhibits viral growth. Clinical trials show it reduces symptoms and boosts immune response in human viral infections like rhinovirus and influenza.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AIT-082, a novel purine derivative with neuroregenerative properties.

    Expert opinion on investigational drugs·2005
    Same author

    AIT-082, a cognitive enhancer, is transported into brain by a nonsaturable influx mechanism and out of brain by a saturable efflux mechanism.

    The Journal of pharmacology and experimental therapeutics·2000
    Same author

    AIT-082, a unique purine derivative, enhances nerve growth factor mediated neurite outgrowth from PC12 cells.

    Neuroscience letters·1995
    Same author

    Effect of AIT-082, a purine analog, on working memory in normal and aged mice.

    Pharmacology, biochemistry, and behavior·1994
    Same author

    A low dose of ethanol impairs working memory in mice in a win-shift foraging paradigm.

    Alcohol (Fayetteville, N.Y.)·1993
    Same author

    Effect of age and strain on working memory in mice as measured by win-shift paradigm.

    Pharmacology, biochemistry, and behavior·1993
    Same journal

    Rhabdomyolysis associated with high-dose cytarabine.

    Cancer treatment reports·1987
    Same journal

    Acute laryngeal edema after single-dose irradiation and doxorubicin.

    Cancer treatment reports·1987
    Same journal

    Timing may be a critical factor in drug therapy.

    Cancer treatment reports·1987
    Same journal

    Prednimustine in advanced malignant melanoma: a phase II study.

    Cancer treatment reports·1987
    Same journal

    Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    Same journal

    Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    See all related articles

    Area of Science:

    • Immunology
    • Virology
    • Toxicology

    Background:

    • Isoprinosine is an antiviral agent with immunomodulatory properties.
    • Preclinical data suggest efficacy against DNA and RNA viruses.
    • Potential to enhance cell-mediated immunity is recognized.

    Purpose of the Study:

    • To evaluate the safety and efficacy of isoprinosine.
    • To assess its antiviral and immunomodulatory effects in human infections.

    Main Methods:

    • Acute and chronic toxicity studies in rodents and non-rodents.
    • In vitro and in vivo studies on viral inhibition and immune response.
    • Clinical trials involving rhinovirus, herpesvirus, and influenza virus infections.

    Main Results:

    Related Experiment Videos

    • Isoprinosine demonstrated low acute and chronic toxicity.
    • Inhibition of DNA and RNA virus replication observed.
    • Enhanced cell-mediated immune responses in vitro and in vivo.
    • Reduced clinical symptoms and improved immune response in human viral infections.

    Conclusions:

    • Isoprinosine is a safe antiviral agent with demonstrated efficacy.
    • It effectively inhibits viral replication and potentiates immune responses.
    • Clinical benefits observed in treating human viral infections.